This message was sent to ##Email## April 5, 2018     Home  |   About   Subscribe  |   Archive  |   Advertise    HEALTH CARE NEWS AND UPDATES New trauma study results show tourniquet practice adopted from the military saves lives and limbs in civilians ACS Civilian trauma medicine has adopted many methods and techniques that have been developed and tested on the battlefield. One such technique, the use of tourniquets to stanch early bleeding in arms and legs, has been shown to improve a trauma victim’s chance of survival. Although the use of tourniquets in civilians had been previously studied, its survival benefit had remained unclear. However, new study results published as an “article in press” on the website of the Journal of the American College of Surgeons demonstrate that the use of tourniquets improves survival in civilian trauma victims. These findings are very timely, as the first National Stop the Bleed Day was just observed across the U.S. on March 31.  READ MORE    SPONSORED CONTENT Promoted by Immunogen, Inc. Mirvetuximab soravtansine, a folate receptor alpha-targeting investigational agent being evaluated in ovarian cancer FORWARD I: A phase 3 study of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer FORWARD II: Clinical trial evaluating mirvetuximab soravtansine combination therapies in ovarian cancer   Overtreatment a concern with RAI for well-differentiated thyroid cancer Oncology Nurse Advisor Patients with well-differentiated thyroid cancer (WDTC) treated with radioactive iodine (RAI) appear to have an increased early risk of developing acute myeloid leukemia (AML) or chronic myeloid leukemia (CML), according to a new study published in the Journal of Clinical Oncology. The study turned up no increased earlier risk for any other hematologic malignancies. The findings suggest that RAI use in patients with WDTC should be limited to patients with high-risk disease features.  READ MORE 'One-stop shops' set to speed up cancer diagnosis BBC News "One-stop shops" aimed at speeding up cancer diagnosis are being introduced across England. The aim is to catch the disease earlier and prevent patients from being referred for several tests for different forms of the illness. Patients often face delays when they have non-specific symptoms. NHS England says this is a "step change" in the way people with suspected cancer are diagnosed and treated. The rapid diagnosis and then treatment of cancer can be vital in saving lives  READ MORE .  PRODUCT SHOWCASE Intraoperative 10-min Rapid immunoassays for Oncology Surgeons Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues. For more details, see our ihcDirect® product list. Two-pronged approach could curb many cases of lung cancer ScienceDaily Lung cancer, a leading killer, has been hard to target with drugs. A team took a metabolic approach, looking at what lung tumor cells need to live and grow. When they removed these factors, tumor growth was almost completely suppressed in a mouse model. Their findings suggest that a combination of existing drugs (IGF-1 inhibitors and inhibitors of protein breakdown) could provide an alternative to chemotherapy in curbing this deadly cancer.  READ MORE The cancer researcher catching scientific fraud at rapid speed The Atlantic While trawling through scientific studies on cancer research in 2015, Jennifer Byrne noticed something strange. One after another, papers were describing strikingly similar experiments involving a particular gene associated with breast cancer and childhood leukemia. Byrne, a professor of molecular oncology at the University of Sydney, recognized the gene immediately because she was part of a team that cloned it two decades earlier. The problem, she realized upon closer inspection, was that the papers, all of them from China, referred to the wrong nucleotide sequence — a unique series of letters that describes the makeup of a given piece of DNA — being used to deactivate the gene and observe the resulting effects in cancer cells.  READ MORE .  PRODUCT SHOWCASE Help Doctors Without Borders Today Donate now to help Doctors Without Borders bring emergency medical care where it is needed most. Doctors Without Borders USA relies on unrestricted donations from private donors so when an emergency strikes we assess the needs and can act fast. Donate today. Stanford scientists combine CRISPR and DNA barcoding to track cancer growth Stanford News Stanford scientists have found a way to modify pairs of cancer-related genes in the lungs of mice and then precisely track individual cells of the resulting tumor — a combined technique that could dramatically speed up cancer research and drug development. The work could finally allow scientists to mimic and then study the genetic diversity of cells found in tumors outside of the lab.  READ MORE Liquid biopsy technology to improve prostate cancer treatment ScienceDaily Prostate cancer is the second most common cancer in men and the fifth leading cause of death from cancer in men worldwide, according to 2012 numbers. While several viable treatment options for prostate cancer exist, many men affected with prostate cancer will not respond to first-line treatments. Researchers have now developed a new technology for liquid biopsy to identify which patients may not respond to standard therapy before it is delivered.  READ MORE     .  SPONSOR SPOTLIGHT      ACS CANCER PROGRAMS UPDATES AJCC Eighth Edition 3rd print in stock AJCC The AJCC Eighth Edition manual third print is in stock at Springer. Pre-ordered manuals will begin shipping to customers today. The AJCC cannot guarantee that customers will receive the corrected third print from any other retailer right now, including Amazon. To place an order, click here.  READ MORE AJCC letter to NCRA registrars AJCC Dear members of the Cancer Registry and Surveillance Community: Many of you recently completed a survey on the implementation of the AJCC Cancer Staging Manual, Eighth Edition. We hear you, we are truly sympathetic and we are committed and available to help with the difficulties you are encountering with the number of corrections to the manual. The AJCC Executive Committee is meeting in April 2018 to carefully review the results of the implementation survey and develop an action plan for mitigating these issues. We are making every effort to ensure that physicians have the most up-to-date information when making their treatment decisions with their cancer patients, and that cancer data collectors have the resources they need to accurately record and submit data to their standard setters. Over the past 18 months, we have worked closely with the NAACCR Site Specific Data Item Task Force and licensed electronic health record vendors to prepare software for the Jan. 1, 2018, implementation date.  READ MORE CQIP 2017 update released Cancer Program- NCDB An update to your CQIP 2017 Annual Report has been released impacting Slide 49 - Number of Major Surgical Resections for Selected Cancers, 2013 - 2015 - My Facility, “Lung Resection” includes all lung cancer resections for major surgeries (Surgical Procedure of Primary Site at This Facility / Codes 30 through 80 / NAACCR Item #670) and Slide 53 - NSCLC Resections, Unadjusted 30, 90 Day Mortality, 95 percent CI, 2013 - 2015 - My Facility vs. All CoC and CoC High Volume, changed to include only Non-Small Cell Lung (NSCLC) cases. Slides that are impacted are denoted as “Updated March 2018.” The remaining CQIP slides remain unchanged. If you have any questions, please contact ncdbcqip@facs.org. CoC launches Special Study ACS-CRP The Commission on Cancer (CoC) initiated a pilot study at 20 CoC-accredited facilities in the fall of 2017 as a component of the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) clinical trial (PIs: Drs. Shelley Hwang, Ann Partridge, Alastair Thompson). The study examines the risks and benefits of active surveillance compared with usual care for patients diagnosed with low risk ductal carcinoma in situ (DCIS), commonly known as stage 0 breast cancer. The pilot study concluded Jan. 1, 2018. Following data analysis, a CoC Special Study will be launched in spring 2018 to investigate outcomes from DCIS treatment retrospectively.  READ MORE 2018 NAPBC Standards Manual now available NAPBC The National Accreditation Program for Breast Centers (NAPBC) has released the 2018 NAPBC Standards Manual. You can download a PDF of the manual from the NAPBC Standards web page. Click the 2018 NAPBC Standards Manual link at the top of the standards web page. If your browser is set to auto-download, check the downloads folder on your computer after clicking the link. The 2018 NAPBC Standards Manual will be available online and as a PDF. The NAPBC will not have printed copies of the manual for purchase. Please contact us at NAPBC@facs.org with any questions or comments.  READ MORE Applications for NAPRC accreditation now being accepted American College of Surgeons - NAPRC The National Accreditation Program for Rectal Cancer (NAPRC) is now accepting applications. The NAPRC was developed to ensure that rectal cancer patients receive appropriate care following a multidisciplinary approach. Programs will be evaluated on the standards and metrics outlined in The National Accreditation Program for Rectal Cancer Standards Manual 2017 (revised October 2017).  READ MORE ACS releases Optimal Resources for Surgical Quality and Safety American College of Surgeons The American College of Surgeons (ACS) is pleased to announce that Optimal Resources for Surgical Quality and Safety is now available for purchase. This manual is intended to serve as a trusted resource for surgical leaders seeking to improve patient care in their institutions, departments and practices. It introduces key concepts in quality, safety and reliability and explores the essential elements that all hospitals should have in place to ensure the delivery of patient-centered care. Specific topics covered include the following: the domains and phases of surgical care, peer and case review, responsibilities of the Surgical Quality Officer, institutional infrastructure, privileging and credentialing, high reliability, applications to the unique surgical disciplines, data analytics, clinical practice guidelines, quality collaboratives and education and training. The manual also includes a look at some of the “soft skills” that influence quality and safety in health care, as well as the individual surgeon’s responsibility to the patient, colleagues and the next generation of surgeons. Optimal Resources for Surgical Quality and Safety is available for $44.95 (includes shipping) for single copies (up to a quantity of nine) or $39.95 (includes shipping) for per copy for 10 copies or more on the ACS website.  IMPORTANT DATES AND DEADLINES Date Event Location June 1 Call for Data closes July 21-24 ACS Quality and Safety Conference Orlando, FL Sept. 5-8 2018 Cancer Programs Conference Chicago, IL Oct. 21-25 ACS Clinical Congress Boston, MA    TRENDING ARTICLES Missed last week's issue? See which articles your colleagues read most. New colon cancer finding could lead to earlier diagnosis — and better outcomes (Medical Xpress) What to do with 2018 cases: Abstract in NAACCR Version 16-compliant Software and Submit to RQRS! (NCDB) Two studies provide a framework for a new quality improvement program for rectal cancer, showing the value of a multidisciplinary team approach (ACS) Genetic testing helps guide treatment in prostate cancer (OncLive) Aggressive growth of common brain tumors linked to single gene (Medical Xpress) Don't be left behind. Click here to see what else you missed.   The Brief Connect with AJCC Connect with CoC Connect with NAPBC Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version  Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs. American College of Surgeons 633 N Saint Clair Street | Chicago, IL, 60611-3211  | 800-621-4111 | Contact Us  Learn how to add us to your safe sender list so our emails get to your inbox. 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063